Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleNivolumab/Ipilimumab Combo Yields Durable Efficacy in Advanced NSCLC.AuthorsKahl, Kristie l.SubjectsANTINEOPLASTIC agents; DRUG efficacy; LUNG cancer; PATIENT safety; SURVIVAL; TREATMENT effectiveness; DISEASE progression; IPILIMUMABPublicationOncology (08909091), 2020, Vol 34, Issue 7, p254ISSN0890-9091Publication typeArticle